Brief: IRLAB Carried Out A Directed Issue Of Sek 70 Mln And Resolves On A Rights Issue Of About Sek 145 Mln

IRLAB Therapeutics AB

13/12/2019 01:33

Dec 12 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * IRLAB HAS CARRIED OUT A DIRECTED ISSUE OF SEK 70 MILLION
AND
RESOLVES ON A RIGHTS ISSUE OF APPROXIMATELY SEK 145 MILLION
    * IRLAB THERAPEUTICS- SUBSCRIPTION PRICE IN DIRECTED ISSUE,
SET AT
SEK 27 PER SHARE AND A TOTAL OF 2.61 MILLION NEW SHARES OF
SERIES A HAVE BEEN ISSUED
    * THE RIGHTS ISSUE OF APPROXIMATELY SEK 145 MILLION
COMPRISES UP
TO 5,388,711 NEW SHARES OF SERIES A
    * IRLAB THERAPEUTICS- TRADING IN SUBSCRIPTION RIGHTS IS
EXPECTED
TO TAKE PLACE ON NASDAQ FIRST NORTH PREMIER GROWTH MARKET DURING
PERIOD 11 - 21 FEB

Source text for Eikon:  ID:nPn97VYz6a 
Further company coverage:  IRLABa.ST 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))